Advances in Cancer Immunotherapy™: A Focus on Immune Checkpoint Inhibitors

When:  Apr 23, 2022 from 08:00 to 12:00 (ET)
This program will be hosted virtually.


Tina Cascone, MD, PhD – The University of Texas MD Anderson

Program Learning Objectives 

  • Describe the mechanisms of immune checkpoint inhibitors.
  • Summarize recent updates in the use of immune checkpoint inhibitors clinically and toxicity management for key disease states.
  • Outline common toxicities with immune checkpoint inhibitors and their management.

For more information on the program, click below.


View the SITC Meeting Code of Conduct.